NAFLD clinical trial activity catching up in China but lacks substantial domestic participation, says GlobalData
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Surana is a chartered accountant with an all-India rank.
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
The scheme is subject to statutory and regulatory approvals as may be necessary.
Ipca Laboratories now holds 58.88% of the paid-up equity share capital of the company.
Subscribe To Our Newsletter & Stay Updated